Top

CardioVascular and Interventional Radiology

Published in:

01-12-2013 | Review/State of the Art

Prostatic Artery Embolization for Enlarged Prostates Due to Benign Prostatic Hyperplasia. How I Do It

Authors: Francisco C. Carnevale, Alberto A. Antunes

Published in: CardioVascular and Interventional Radiology | Issue 6/2013

Abstract

Prostatic artery embolization (PAE) has emerged as an alternative to surgical treatments for benign prostatic hyperplasia (BPH). Patient selection and refined technique are essential for good results. Urodynamic evaluation and magnetic resonance imaging are very important and technical limitations are related to elderly patients with tortuous and atherosclerotic vessels, anatomical variations, difficulty visualizing and catheterizing small diameter arteries feeding the prostate, and the potential risk of bladder and rectum ischemia. The use of small-diameter hydrophilic microcatheters is mandatory. Patients can be treated safely by PAE with low rates of side effects, reducing prostate volume with clinical symptoms and quality of life improvement without urinary incontinence, ejaculatory disorders, or erectile dysfunction. A multidisciplinary approach with urologists and interventional radiologists is essential to achieve better results.

Wei JT, Calhoun E, Jacobsen SJ (2005) Urologic disease in America project: benign prostatic hyperplasia. J Urol 173(4):1256–1261PubMedCrossRef

Emberton M, Andriole GL, de la Rosette J et al (2003) Benign prostatic hyperplasia. A progressive disease of aging men. Urology 61:267–273PubMedCrossRef

Ziada A, Rosenblum M, Crawford ED (1999) Benign prostatic hyperplasia: an overview. Urology 53:1–6PubMedCrossRef

AUA Practice Guidelines Committee (2003) AUA guideline on management of benign prostatic hyperplasia. I. Diagnosis and treatment recommendations. J Urol 170:530–547CrossRef

Bramson H, Hermann D, Batchelor K et al (1997) Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. J Pharmacol Exp Ther 282:1496PubMed

Kramer B, Hagerty K, Justman S et al (2009) Use of 5-α-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline Summary. J Clin Oncol 27:1502PubMedCrossRef

Pareek G, Shevchuk M, Armenakas N et al (2003) The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients. J Urol 169:20PubMedCrossRef

Canda AE, Mungan MU, Yilmaz O et al (2006) Effects of finasteride on the vascular surface density, number of microvessels and vascular endothelial growth factor expression of the rat prostate. Int Urol Nephrol 38:275PubMedCrossRef

Kaplan SA (2005) Factors in predicting failure with medical therapy for BPH. Rev Urol 7(Suppl 7):S34–S39

10.

McVary KT (2006) BPH: epidemiology and comorbidities. Am J Manage Care 12(5 Suppl):S122–S128

11.

Chute CG, Panser LA, Girman CJ et al (1993) The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 150:85–89PubMed

12.

Rubenstein J, McVary KT (2003) Transurethral microwave thermotherapy for benign prostatic hyperplasia. Int Braz J Urol 29:251–263

13.

Muruve NA, Steinbecker K (2010) Transurethral needle ablation of the prostate (TUNA). http://emedicine.medscape.com/article/ 449477-overview

14.

Appleton DS, Sibley GN, Doyle PT (1988) Internal iliac artery embolisation for the control of severe bladder and prostate haemorrhage. Br J Urol 61:45–47PubMedCrossRef

15.

Michel F, Dubruille T, Cercueil JP (2002) Arterial embolization for massive hematuria following transurethral prostatectomy. J Urol 168:2550–2551PubMedCrossRef

16.

Rastinehad AR, Caplin DM, Ost MC et al (2008) Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin. Urology 71:181–184PubMedCrossRef

17.

DeMeritt JS, Elmasri FF, Esposito MP et al (2000) Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol 11:700–767CrossRef

18.

Carnevale FC, Antunes AA, da Motta Leal Filho JM et al (2010) Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients. Cardiovasc Intervent Radiol 33:355–361PubMedCrossRef

19.

Carnevale FC, da Motta-Leal-Filho JM, Antunes AA et al (2011) Midterm follow-up after prostate embolization in two patients with benign prostatic hyperplasia. Cardiovasc Intervent Radiol 34:1330–1333PubMedCrossRef

20.

Pisco JM, Pinheiro LC, Bilhim T et al (2011) Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vasc Interv Radiol 22(1):11–19PubMedCrossRef

21.

Schafer W, Abrams P, Liao LM et al (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure flow studies. Neurourol Urodyn 21:261–274PubMedCrossRef

22.

Abrams P (1999) Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 84(1):14–15PubMedCrossRef

23.

Clegg EJ (1955) The arterial supply of the human prostate and seminal vesicles. J Anat 89:209–216PubMed

24.

Bilhim T, Pisco JM, Furtado A et al (2011) Prostatic arterial supply: demonstration by multirow detector angio CT and catheter angiography. Eur Radiol 21(5):1119–1126PubMedCrossRef

25.

Carnevale FC, da Motta-Leal-Filho JM, Antunes AA et al (2013) Quality of life and clinical symptoms improvement support prostatic artery embolization for patients with acute urinary retention due to benign prostatic hyperplasia. J Vasc Interv Radiol 24(4):535–542PubMedCrossRef

26.

National Cancer Institute (2009) Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0 Published: May 28, 2009 (V4.03: June 14, 2010) U.S. Department of Health and Human Services National Institute of Health (NIH) Publication no. 09-5410. http://evs.nci.nih.gov/Ftp1/CTCAE/Abont.html. Accessed 16 May 2013

27.

Antunes AA, Carnevale FC, da Motta-Leal-Filho JM et al (2013) Clinical, laboratorial and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia: a prospective single center pilot study. Cardiovasc Intervent Radiol 36(4):978–986

Title: Prostatic Artery Embolization for Enlarged Prostates Due to Benign Prostatic Hyperplasia. How I Do It
Authors: Francisco C. Carnevale
Alberto A. Antunes
Publication date: 01-12-2013
Publisher: Springer US
Published in: CardioVascular and Interventional Radiology / Issue 6/2013
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI: https://doi.org/10.1007/s00270-013-0680-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prostatic Artery Embolization for Enlarged Prostates Due to Benign Prostatic Hyperplasia. How I Do It

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2013

Letter: Inferior Vena Cava Filter Placement and Retrieval in a Patient with Dual IVC

Permanent Cortical Blindness After Bronchial Artery Embolization

Comparing Intra-Arterial Chemotherapy Combined With Intravesical Chemotherapy Versus Intravesical Chemotherapy Alone: A Randomised Prospective Pilot Study for T1G3 Bladder Transitional Cell Carcinoma After Bladder-Preserving Surgery

Interventional Radiological Treatment of Perihepatic Vascular Stenosis or Occlusion in Pediatric Patients After Liver Transplantation

Epidural Analgesia Versus Patient-Controlled Analgesia for Pain Relief in Uterine Artery Embolization for Uterine Fibroids: A Decision Analysis

Value of Duplex Ultrasound Assistance for Thromboaspiration and Dilation of Thrombosed Native Arterio-Venous Fistulae